Possible Sanctions For Takeda In Actos Bladder Cancer MDL

Law360, New York (January 29, 2014, 8:41 PM EST) -- A Louisiana federal judge has found that Takeda Pharmaceuticals America Inc. breached a duty to preserve evidence in multidistrict litigation claiming its anti-diabetic drug Actos causes bladder cancer, saying she would decide what sanctions are warranted during a bellwether trial starting Monday.

Takeda put a litigation hold on documents and electronic data related to Actos in 2002, yet repeatedly destroyed emails and other documents with information about the drug over much of the next decade, U.S. District Judge Rebecca Doherty ruled in a 75-page opinion on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.